Aammaad Shams - Mar 1, 2024 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Accounting Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol
EVH
Transactions as of
Mar 1, 2024
Transactions value $
-$88,399
Form type
4
Date filed
3/5/2024, 07:18 PM
Previous filing
Aug 3, 2023
Next filing
Aug 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +7.49K +14.97% $0.00 57.5K Mar 1, 2024 Direct F1, F2, F3
transaction EVH Class A Common Stock Tax liability -$88.4K -2.57K -4.47% $34.41 54.9K Mar 1, 2024 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027.
F3 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F4 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.